Literature DB >> 5229656

The influence of morphology on prognosis in acute leukemia.

R Hasselback, J Curtis, M Soots, G L Robertson, D H Cowan, G D Hart.   

Abstract

The presence of definite cytoplasmic granulation in at least some of the malignant cells was used as the sole criterion to separate 156 patients with acute leukemia into two groups: 110 with myeloblastic (AML), and 46 with lymphoblastic or stem cell leukemia (ALL). The median survival from the onset of symptoms in patients with AML was 20 weeks, and those with ALL 37 weeks. The difference in survival in these two groups is much greater for patients under the age of 25 than for those over the age of 25.

Entities:  

Mesh：

Year:  1967        PMID： 5229656      PMCID： PMC1923070     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


  6 in total

1.  Viral-related information in oncornavirus-lik particles isolated from cultures of marrow cells from leukemic patients in relapse and remission.

Authors:  T W Mak; S Kurtz; J Manaster; D Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

2.  Treatment of acute myeloblastic leukemia in adults: remission induction with a combination of cyclophosphamide, cytarabine and vincristine.

Authors:  H Abu-Zahra; A Clarysse; D H Cowan; R Hasselback; D E Bergsagel
Journal:  Can Med Assoc J       Date:  1972-12-09       Impact factor: 8.262

3.  Particles with characteristics of leukoviruses in cultures of marrow cells from leukemic patients in remission and relapse.

Authors:  T W Mak; J Manaster; A F Howatson; E A McCulloch; J E Till
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

4.  Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.

Authors:  J E Curtis; D H Cowan; D E Bergsagel; R Hasselback; E A McCulloch
Journal:  Can Med Assoc J       Date:  1975-08-23       Impact factor: 8.262

5.  Single-cell immunofluorescence assay for terminal transferase: human leukaemic and non-leukaemic cells.

Authors:  S Okamura; F Crane; N Jamal; H A Messner; T W Mak
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

6.  Reverse transcriptase activity: increase in marrow cultures from leukaemic patients in relapse and remission.

Authors:  T W Mak; M T Aye; H Messner; R Sheinin; J E Till; E A McCulloch
Journal:  Br J Cancer       Date:  1974-06       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.